Baraclude 0.5 mg Oral Solution 210 ML

Baraclude 0.5 mg Oral Solution is used to treat chronic hepatitis B virus (HBV) infection. Hepatitis B is a severe liver infection caused by the hepatitis B virus (HBV). It is highly contagious (spreads from one person to another) and spreads through intimate contact with the infected person, direct contact with infected blood, being pricked with a contaminated needle, using a razor or any other personal items with leftovers of infected fluid or even transfer from mother to baby during birth.

Baraclude 0.5 mg Oral Solution contains Entecavir, an antiviral drug that works by inhibiting viral DNA polymerase enzyme action in the liver cells, which is essential for the virus to multiply. Therefore, it prevents the virus from replicating and reduces the amount of hepatitis B virus in the body.

Take Baraclude 0.5 mg Oral Solution as prescribed by your doctor. You are advised to take Baraclude 0.5 mg Oral Solution for as long as your doctor has prescribed it for you based on your medical condition. In some cases, you may experience dizziness, headache, nausea, vomiting, drowsiness, extreme tiredness, insomnia (inability to sleep), diarrhoea, or indigestion. Most of these side effects of Baraclude 0.5 mg Oral Solution do not require medical attention and typically resolve on their own over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to Baraclude 0.5 mg Oral Solution or any other medicines, please tell your doctor. If you are pregnant or breastfeeding, please consult a doctor before taking Baraclude 0.5 mg Oral Solution . It is recommended to use effective contraceptive methods while using Baraclude 0.5 mg Oral Solution to avoid pregnancy. Baraclude 0.5 mg Oral Solution is not recommended for children below 2 years of age. If you experience stomach pain, vomiting, or nausea while taking Baraclude 0.5 mg Oral Solution , it might indicate the development of lactic acidosis. This rare but serious side effect has occasionally been fatal. Lactic acidosis occurs more often in women, particularly if they are very overweight. Your doctor will monitor you regularly while you are receiving treatment. If you have HIV/AIDS, kidney or liver problems, inform your doctor before taking Baraclude 0.5 mg Oral Solution .

Baraclude 0.5 mg Oral Solution is used in the treatment of chronic (long-term) hepatitis B virus (HBV) infection. This medication does not cure the infection, but it helps reduce the amount of virus in the body and prevents further liver damage. The detailed uses of Baraclude 0.5 mg Oral Solution are as follows:

• Treatment of Chronic HBV Infection in Adults: Baraclude 0.5 mg Oral Solution is indicated for adults with chronic HBV infection, including those with compensated liver disease (liver is damaged but still functions properly) and decompensated liver disease (liver is damaged and no longer functions properly).
• Treatment of Chronic HBV Infection in Children: Baraclude 0.5 mg Oral Solution is also used to treat chronic HBV infection in children and adolescents aged 2 to under 18 years who have compensated liver disease.

• Baraclude 0.5 mg Oral Solution can be taken on an empty stomach, preferably 2 hours before or after a meal.
• It is usually taken once daily at the same time each day or as prescribed by your doctor.
• Swallow Baraclude 0.5 mg Oral Solution as a whole with a glass of water.
• Do not break, crush, or chew it.

Baraclude 0.5 mg Oral Solution contains Entecavir, an antiviral drug used to treat chronic hepatitis B virus (HBV) infection. Baraclude 0.5 mg Oral Solution works by inhibiting the viral DNA polymerase enzyme action in the liver cells, which is essential for the virus to multiply. Therefore, it prevents the virus from replicating and reduces the amount of hepatitis B virus in the body. Thus, it decreases damage to the liver and improves liver function.

If you are allergic to Baraclude 0.5 mg Oral Solution or any other medicines, please tell your doctor. If you are pregnant or breastfeeding, please consult a doctor before taking Baraclude 0.5 mg Oral Solution . It is recommended to use effective contraceptive methods while using Baraclude 0.5 mg Oral Solution to avoid pregnancy. Baraclude 0.5 mg Oral Solution is not recommended for children below 2 years of age. You are advised to take proper precautions if you are infected with hepatitis B virus infection to prevent infection from spreading to others through sexual contact or body fluids. Hepatitis B vaccine should be taken to avoid Hepatitis B virus infection. If you experience stomach pain, vomiting or nausea while taking Baraclude 0.5 mg Oral Solution , it might indicate lactic acidosis development. This rare but serious side effect has occasionally been fatal. Lactic acidosis occurs more often in women, particularly if they are very overweight. Your doctor will monitor you regularly while you are receiving. If you have HIV/AIDS, kidney or liver problems, inform your doctor before taking Baraclude 0.5 mg Oral Solution .